TG Therapeutics 1 article

TG Therapeutics is an antibody and protein-therapeutics company whose biologic strategy centers on B-cell therapeutics, with B-cell depletion therapy defining a key target, format or immune mechanism. Its protein-engineering strategy also spans multiple sclerosis immunotherapy and adaptive immune cell modulation, with antibody-dependent cellular cytotoxicity defining a key receptor, immune-cell or target-binding feature of the therapeutic design. GenoMethods keeps antibody formats, molecular targets and individual biologics separate from the company; the protein-therapeutics profile of TG Therapeutics also includes autoimmune neurologic disease treatment.